Literature DB >> 11027249

Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.

T Xie1, U D McCann, S Kim, J Yuan, G A Ricaurte.   

Abstract

Hyperthermia exacerbates and hypothermia attenuates methamphetamine (METH)-induced dopamine (DA) neurotoxicity. The mechanisms underlying these temperature effects are unknown. Given the essential role of the DA transporter (DAT) in the expression of METH-induced DA neurotoxicity, we hypothesized that the effect of temperature on METH-induced DA neurotoxicity is mediated, at least in part, at the level of the DAT. To test this hypothesis, the effects of small, physiologically relevant temperature changes on DAT function were evaluated in two types of cultured neuronal cells: (1) a neuroblastoma cell line stably transfected with human DAT cDNA and (2) rat embryonic mesencephalic primary cells that naturally express the DAT. Temperatures for studies of DAT function were selected based on core temperature measurements in animals exposed to METH under usual ambient (22 degrees C) and hypothermic (6 degrees C) temperature conditions, where METH neurotoxicity was fully expressed and blocked, respectively. DAT function, determined by measuring accumulation of radiolabeled DA and 1-methyl-4-phenylpyridinium (MPP(+)), was found to directly correlate with temperature, with higher levels of substrate uptake at 40 degrees C, intermediate levels at 37 degrees C, and lower levels at 34 degrees C. DAT-mediated accumulation of METH also directly correlated with temperature, with greater accumulation at higher temperatures. These findings indicate that relatively small, physiologically relevant changes in temperature significantly alter DAT function and intracellular METH accumulation, and suggest that the effect of temperature on METH-induced DA neurotoxicity is mediated, at least in part, at the level of the DAT.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027249      PMCID: PMC6772867     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  65 in total

1.  Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines.

Authors:  K B Burrows; W L Nixdorf; B K Yamamoto
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

2.  Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice.

Authors:  P K Sonsalla; D E Riordan; R E Heikkila
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

3.  Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.

Authors:  J F Cubells; S Rayport; G Rajendran; D Sulzer
Journal:  J Neurosci       Date:  1994-04       Impact factor: 6.167

4.  Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium.

Authors:  C Pifl; B Giros; M G Caron
Journal:  J Neurosci       Date:  1993-10       Impact factor: 6.167

5.  Effect of 7-nitroindazole on body temperature and methamphetamine-induced dopamine toxicity.

Authors:  B T Callahan; G A Ricaurte
Journal:  Neuroreport       Date:  1998-08-24       Impact factor: 1.837

6.  Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.

Authors:  F Fumagalli; R R Gainetdinov; K J Valenzano; M G Caron
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

7.  Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

Authors:  J E Malberg; L S Seiden
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

8.  The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum.

Authors:  C Pu; J E Fisher; G D Cappon; C V Vorhees
Journal:  Brain Res       Date:  1994-06-27       Impact factor: 3.252

9.  Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse.

Authors:  D B Miller; J P O'Callaghan
Journal:  J Pharmacol Exp Ther       Date:  1994-08       Impact factor: 4.030

10.  Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum.

Authors:  G A Ricaurte; J W Langston; L E DeLanney; I Irwin; J D Brooks
Journal:  Neurosci Lett       Date:  1985-09-06       Impact factor: 3.046

View more
  33 in total

1.  Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro.

Authors:  Nidhi Kaushal; Matthew J Robson; Abagail Rosen; Christopher R McCurdy; Rae R Matsumoto
Journal:  Eur J Pharmacol       Date:  2013-12-28       Impact factor: 4.432

2.  Changes in gene expression linked to methamphetamine-induced dopaminergic neurotoxicity.

Authors:  Tao Xie; Liqiong Tong; Tanya Barrett; Jie Yuan; George Hatzidimitriou; Una D McCann; Kevin G Becker; David M Donovan; George A Ricaurte
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

3.  Differential effects of environment-induced changes in body temperature on modafinil's actions against methamphetamine-induced striatal toxicity in mice.

Authors:  Mariana Raineri; Betina González; Celeste Rivero-Echeto; Javier A Muñiz; María Laura Gutiérrez; Carolina I Ghanem; Jean Lud Cadet; Edgar García-Rill; Francisco J Urbano; Veronica Bisagno
Journal:  Neurotox Res       Date:  2014-09-27       Impact factor: 3.911

4.  Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo.

Authors:  Nidhi Kaushal; Michael J Seminerio; Matthew J Robson; Christopher R McCurdy; Rae R Matsumoto
Journal:  Eur Neuropsychopharmacol       Date:  2012-08-24       Impact factor: 4.600

Review 5.  Physiological fluctuations in brain temperature as a factor affecting electrochemical evaluations of extracellular glutamate and glucose in behavioral experiments.

Authors:  Eugene A Kiyatkin; Ken T Wakabayashi; Magalie Lenoir
Journal:  ACS Chem Neurosci       Date:  2013-03-14       Impact factor: 4.418

6.  Brain and body hyperthermia associated with heroin self-administration in rats.

Authors:  Eugene A Kiyatkin; Roy A Wise
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

7.  D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice.

Authors:  N Granado; S Ares-Santos; R Moratalla
Journal:  Neurotox Res       Date:  2013-11-21       Impact factor: 3.911

8.  Assessing the role of dopamine in the differential neurotoxicity patterns of methamphetamine, mephedrone, methcathinone and 4-methylmethamphetamine.

Authors:  John H Anneken; Mariana Angoa-Perez; Girish C Sati; David Crich; Donald M Kuhn
Journal:  Neuropharmacology       Date:  2017-08-26       Impact factor: 5.250

9.  Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile.

Authors:  Melanie Mueller; Concepcion Maldonado-Adrian; Jie Yuan; Una D McCann; George A Ricaurte
Journal:  J Pharmacol Exp Ther       Date:  2012-12-03       Impact factor: 4.030

10.  Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate.

Authors:  T J Volz
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.